BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 34407751)

  • 1. Modified arteriosclerosis score predicts the outcomes of diabetic kidney disease.
    Zhang Y; Jiang Q; Xie J; Qi C; Li S; Wang Y; Him YH; Chen Z; Zhang S; Li Q; Zhu Y; Li R; Liang X; Bai X; Wang W
    BMC Nephrol; 2021 Aug; 22(1):281. PubMed ID: 34407751
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of tubulointerstitial markers in differential diagnosis and prognosis in patients with type 2 diabetes and biopsy proven diabetic kidney disease.
    Wang X; Ren L; Huang Y; Feng Z; Zhang G; Dai H
    Clin Chim Acta; 2023 Jul; 547():117448. PubMed ID: 37331550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Kidney Histopathology and Prediction of Kidney Failure: A Retrospective Cohort Study.
    Eadon MT; Schwantes-An TH; Phillips CL; Roberts AR; Greene CV; Hallab A; Hart KJ; Lipp SN; Perez-Ledezma C; Omar KO; Kelly KJ; Moe SM; Dagher PC; El-Achkar TM; Moorthi RN
    Am J Kidney Dis; 2020 Sep; 76(3):350-360. PubMed ID: 32336487
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tissue expression of tubular injury markers is associated with renal function decline in diabetic nephropathy.
    Hwang S; Park J; Kim J; Jang HR; Kwon GY; Huh W; Kim YG; Kim DJ; Oh HY; Lee JE
    J Diabetes Complications; 2017 Dec; 31(12):1704-1709. PubMed ID: 29037450
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nomogram analysis of the influencing factors of rapid renal decline in patients with biopsy-proven diabetic nephropathy in type 2 diabetes.
    Ma Y; Ren Y; Hui D; Zhang L; Jiao C; Xie H
    Clin Nephrol; 2023 Jun; 99(6):274-282. PubMed ID: 36928261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Glomerular Complement C4c Deposition With the Progression of Diabetic Kidney Disease in Patients With Type 2 Diabetes.
    Duan S; Sun L; Nie G; Chen J; Zhang C; Zhu H; Huang Z; Qian J; Zhao X; Xing C; Zhang B; Yuan Y
    Front Immunol; 2020; 11():2073. PubMed ID: 32983156
    [No Abstract]   [Full Text] [Related]  

  • 7. Urinary chemokine C-X-C motif ligand 16 and endostatin as predictors of tubulointerstitial fibrosis in patients with advanced diabetic kidney disease.
    Lee YH; Kim KP; Park SH; Kim DJ; Kim YG; Moon JY; Jung SW; Kim JS; Jeong KH; Lee SY; Yang DH; Lim SJ; Woo JT; Rhee SY; Chon S; Choi HY; Park HC; Jo YI; Yi JH; Han SW; Lee SH
    Nephrol Dial Transplant; 2021 Jan; 36(2):295-305. PubMed ID: 31598726
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Renal arterial resistive index is associated with severe histological changes and poor renal outcome during chronic kidney disease.
    Bigé N; Lévy PP; Callard P; Faintuch JM; Chigot V; Jousselin V; Ronco P; Boffa JJ
    BMC Nephrol; 2012 Oct; 13():139. PubMed ID: 23098365
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Validation of the interstitial fibrosis and tubular atrophy on the new pathological classification in patients with diabetic nephropathy: A single-center study in China.
    Zhu X; Xiong X; Yuan S; Xiao L; Fu X; Yang Y; Tang C; He L; Liu F; Sun L
    J Diabetes Complications; 2016 Apr; 30(3):537-41. PubMed ID: 26796433
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum hemoglobin concentration and risk of renal function decline in early stages of diabetic kidney disease: a nationwide, biopsy-based cohort study.
    Yamanouchi M; Furuichi K; Shimizu M; Toyama T; Yamamura Y; Oshima M; Kitajima S; Hara A; Iwata Y; Sakai N; Oba Y; Matsuoka S; Ikuma D; Mizuno H; Suwabe T; Hoshino J; Sawa N; Yuzawa Y; Kitamura H; Suzuki Y; Sato H; Uesugi N; Ueda Y; Nishi S; Yokoyama H; Nishino T; Samejima K; Kohagura K; Shibagaki Y; Makino H; Matsuo S; Ubara Y; Wada T
    Nephrol Dial Transplant; 2022 Feb; 37(3):489-497. PubMed ID: 34028524
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical and pathological predictors of estimated GFR decline in patients with type 2 diabetes and overt proteinuric diabetic nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Diabetes Metab Res Rev; 2015 Sep; 31(6):572-81. PubMed ID: 25533683
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polar vasculosis is associated with better kidney outcome in type 2 diabetes with biopsy-proven diabetic kidney disease: A multicenter cohort study.
    Shimizu M; Furuichi K; Toyama T; Yamanouchi M; Hoshino J; Kitajima S; Hara A; Iwata Y; Sakai N; Yuzawa Y; Kitamura H; Sato H; Shibagaki Y; Suzuki Y; Uesugi N; Ueda Y; Kohagura K; Samejima K; Tsuruya K; Nishi S; Nishino T; Makino H; Matsuo S; Ubara Y; Yokoyama H; Wada T;
    J Diabetes Investig; 2023 Nov; 14(11):1268-1278. PubMed ID: 37483063
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pathological scoring system to predict renal outcome in diabetic nephropathy.
    Hoshino J; Mise K; Ueno T; Imafuku A; Kawada M; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Hara S; Fujii T; Ohashi K; Ubara Y; Takaichi K
    Am J Nephrol; 2015; 41(4-5):337-44. PubMed ID: 26067713
    [TBL] [Abstract][Full Text] [Related]  

  • 14. C3c deposition predicts worse renal outcomes in patients with biopsy-proven diabetic kidney disease in type 2 diabetes mellitus.
    Li MR; Sun ZJ; Chang DY; Yu XJ; Wang SX; Chen M; Zhao MH
    J Diabetes; 2022 Apr; 14(4):291-297. PubMed ID: 35322566
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Association of urinary acidification function with the progression of diabetic kidney disease in patients with type 2 diabetes.
    Zhu H; Liu X; Zhang C; Li Q; An X; Liu S; Wu L; Zhang B; Yuan Y; Xing C
    J Diabetes Complications; 2019 Nov; 33(11):107419. PubMed ID: 31473080
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prognostic Value of Tubulointerstitial Lesions, Urinary N-Acetyl-β-d-Glucosaminidase, and Urinary β2-Microglobulin in Patients with Type 2 Diabetes and Biopsy-Proven Diabetic Nephropathy.
    Mise K; Hoshino J; Ueno T; Hazue R; Hasegawa J; Sekine A; Sumida K; Hiramatsu R; Hasegawa E; Yamanouchi M; Hayami N; Suwabe T; Sawa N; Fujii T; Hara S; Ohashi K; Takaichi K; Ubara Y
    Clin J Am Soc Nephrol; 2016 Apr; 11(4):593-601. PubMed ID: 26801478
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Urinary soluble CD90 predicts renal prognosis in patients with diabetic kidney disease.
    Wu L; Chang DY; Zhang LX; Chen M; Zhao MH
    Ann Transl Med; 2021 Feb; 9(4):282. PubMed ID: 33708909
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Impact of the relationship between hemoglobin levels and renal interstitial fibrosis on long-term outcomes in type 2 diabetes with biopsy-proven diabetic nephropathy.
    Shimizu M; Furuichi K; Kitajima S; Toyama T; Oshima M; Ogura H; Sato K; Nakagawa S; Yamamura Y; Miyagawa T; Hara A; Iwata Y; Sakai N; Kitagawa K; Yoshimura M; Yokoyama H; Wada T
    BMC Nephrol; 2021 Sep; 22(1):319. PubMed ID: 34560842
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Renal Histologic Analysis Provides Complementary Information to Kidney Function Measurement for Patients with Early Diabetic or Hypertensive Disease.
    Quinn GZ; Abedini A; Liu H; Ma Z; Cucchiara A; Havasi A; Hill J; Palmer MB; Susztak K
    J Am Soc Nephrol; 2021 Nov; 32(11):2863-2876. PubMed ID: 34348909
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The association of hematuria on kidney clinicopathologic features and renal outcome in patients with diabetic nephropathy: a biopsy-based study.
    Wu Y; Zhang J; Wang Y; Wang T; Han Q; Guo R; Zhang R; Ren H; Zhu Y; Xu H; Li L; Tong N; Liu F
    J Endocrinol Invest; 2020 Sep; 43(9):1213-1220. PubMed ID: 32147762
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.